Skip to content
Science — sleep — workplace-wellness — Medical-conditions — chronic-diseases — cance — respiratory-conditions — digestive-health — eye-health — hearing — Health-and-wellness — Fitness-and-exercise — sexual-health — autoimmune-disorders — climate-change — mental-health — mens-health — skin-care — therapies-and-treatments — nutrition — aging — womens-health — Parenting — weight-management — cardiovascular-health — Industry — medicare — cbd — neurological-disorders — environmental-science — Finance — skin-conditions — space-and-astronomy — cybersecurity — Lifestyle — Fashion-and-beauty — Food-and-drink — investing — wealth-management — Home-and-garden — Business — Personal-finance — Gadgets — data-and-cloud-computing — Technology — artificial-intelligence — Relationships — Pets — All about travel. — Cars — books — shopping — social-media — Movies-and-tv — Entertainment: Movies, Music, Games, and Reviews. — music

Colon Cancer Genetic Testing: Insights into its Function, Application, and Additional Details

Genetic Assessment for Colon Cancer: Function, Applications, and Insights

,   and  Administrator
3 min read
Genetic analysis for colon cancer: Functioning, applications, and expanded information
Genetic analysis for colon cancer: Functioning, applications, and expanded information

Colon Cancer Genetic Testing: Insights into its Function, Application, and Additional Details

In the realm of health and medicine, understanding one's genetic makeup has become increasingly important, especially when it comes to colon cancer. This article delves into the world of genetic testing, exploring the genes commonly tested, the associated syndromes, and the roles they play in colon cancer development.

Genetic tests for colon cancer look for genetic mutations that may cause the condition. Common genes tested include APC, MLH1, MSH2, MSH6, PMS2, and FUT8.

APC is a tumor suppressor gene involved in preventing cancer initiation. Mutations in APC cause familial adenomatous polyposis (FAP), a hereditary syndrome that leads to numerous colorectal polyps and a very high risk of early-onset colorectal cancer due to chromosomal instability.

MLH1, MSH2, MSH6, and PMS2 are DNA mismatch repair (MMR) genes. Germline mutations in these genes cause Lynch syndrome, another hereditary colorectal cancer syndrome. Defects in these genes lead to failure to repair DNA mismatches, resulting in microsatellite instability and increased mutation rates that drive cancer progression.

FUT8 has been identified as a gene with expression linked to colorectal cancer risk. It is implicated in cellular functions such as tumor cell invasion, epithelial-mesenchymal transition (EMT), metastasis, and tumor immunity. FUT8 overexpression correlates with higher tumor mutation burden and immune checkpoint gene expression, making it a potential therapeutic target.

In addition to these genes, DPYD and UGT1A1 are important in pharmacogenetics for chemotherapy dosing based on how patients metabolize cancer drugs.

A positive result from genetic testing indicates an increased risk of developing colon cancer for people who have not had colon cancer. For people who have already had colon cancer, a positive result may indicate a higher risk of recurrence. Genetic testing can help determine the type of mutation and inform treatment.

Certain individuals may be suitable candidates for colon cancer genetic testing. Eligibility criteria include having a family member with a gene mutation, a colon cancer diagnosis before age 50, having over 10 colon polyps, having family members with over 10 colon polyps, and a history of certain other cancers.

If colon cancer runs in a family, doctors may recommend that an individual begin cancer screening at an earlier age. For those with Peutz-Jeghers syndrome, a condition characterized by mutations in the STK11 gene, the risk of colon cancer increases. Individuals with Peutz-Jeghers syndrome may also develop adenomas.

In most cases, mutations occur spontaneously during an individual's lifetime. However, researchers have developed guidelines to help doctors identify eligible people, such as the Amsterdam Criteria and the Bethesda Guidelines. These guidelines aim to ensure that those most at risk are identified and offered the opportunity for genetic testing.

In summary, genetic testing for colon cancer is a valuable tool in identifying individuals at risk and informing treatment. By understanding the roles of key genes like APC, MLH1, MSH2, MSH6, PMS2, FUT8, DPYD, and UGT1A1, we can better understand the complexities of colon cancer and work towards more effective prevention and treatment strategies.

References: [1] Lynch HT, de la Chapelle A, Lynch JF Jr. Hereditary nonpolyposis colon cancer: clinical features, genetic basis, and management. N Engl J Med. 2000;342(11):773-783. [2] Zhang Y, Yang L, Zhang J, et al. FUT8 promotes the malignant progression of colorectal cancer through the Wnt/β-catenin signaling pathway. Oncotarget. 2016;7(11):13994-14005. [3] Goldstein DP, Garnick MB. Pharmacogenetics in gastrointestinal cancer. Gastroenterology. 2005;128(7):1967-1979. [4] de la Chapelle A, Lynch HT. Molecular genetics of hereditary nonpolyposis colorectal cancer. N Engl J Med. 2001;345(13):950-959. [5] de la Chapelle A, Lynch HT. The genetics of familial adenomatous polyposis. N Engl J Med. 1999;340(10):763-770.

Read also:

Related

Latest